85 related articles for article (PubMed ID: 19552607)
1. Emerging drugs for hepatic encephalopathy.
Riggio O; Ridola L
Expert Opin Emerg Drugs; 2009 Sep; 14(3):537-49. PubMed ID: 19552607
[TBL] [Abstract][Full Text] [Related]
2. Antibiotics in the management of hepatic encephalopathy: an evidence-based review.
Rothenberg ME; Keeffe EB
Rev Gastroenterol Disord; 2005; 5 Suppl 3():26-35. PubMed ID: 17713457
[TBL] [Abstract][Full Text] [Related]
3. Hepatic encephalopathy therapy: An overview.
Riggio O; Ridola L; Pasquale C
World J Gastrointest Pharmacol Ther; 2010 Apr; 1(2):54-63. PubMed ID: 21577297
[TBL] [Abstract][Full Text] [Related]
4. [Pathogenesis of cirrhotic hepatic encephalopathy. Treatment implications].
García-Compean D; Michel H
Rev Gastroenterol Mex; 1995; 60(3):159-68. PubMed ID: 7481451
[TBL] [Abstract][Full Text] [Related]
5. Experimental models of hepatic encephalopathy: ISHEN guidelines.
Butterworth RF; Norenberg MD; Felipo V; Ferenci P; Albrecht J; Blei AT;
Liver Int; 2009 Jul; 29(6):783-8. PubMed ID: 19638106
[TBL] [Abstract][Full Text] [Related]
6. Review article: bacterial flora and pathogenesis in hepatic encephalopathy.
Williams R
Aliment Pharmacol Ther; 2007 Feb; 25 Suppl 1():17-22. PubMed ID: 17295848
[TBL] [Abstract][Full Text] [Related]
7. Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy.
Hassanein T; Blei AT; Perry W; Hilsabeck R; Stange J; Larsen FS; Brown RS; Caldwell S; McGuire B; Nevens F; Fontana R
Am J Gastroenterol; 2009 Jun; 104(6):1392-400. PubMed ID: 19455117
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications.
Monfort P; Cauli O; Montoliu C; Rodrigo R; Llansola M; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V
Neurochem Int; 2009; 55(1-3):106-12. PubMed ID: 19428813
[TBL] [Abstract][Full Text] [Related]
9. Minimal hepatic encephalopathy: time to recognise and treat.
Dhiman RK; Chawla YK
Trop Gastroenterol; 2008; 29(1):6-12. PubMed ID: 18564660
[TBL] [Abstract][Full Text] [Related]
10. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
Sharma BC; Sharma P; Agrawal A; Sarin SK
Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
[TBL] [Abstract][Full Text] [Related]
11. [Ornithine aspartate in hepatic encephalopathy: an established new therapeutic approach. Overview and results of current randomized studies].
Krüger B; Held C; Kircheis G
Z Arztl Fortbild (Jena); 1994 Sep; 88(9):673-9. PubMed ID: 7975752
[No Abstract] [Full Text] [Related]
12. Role of antibiotics in the management of hepatic encephalopathy.
Maddrey WC
Rev Gastroenterol Disord; 2005; 5 Suppl 1():S3-9. PubMed ID: 15976746
[TBL] [Abstract][Full Text] [Related]
13. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
[TBL] [Abstract][Full Text] [Related]
14. Treatment of portal systemic encephalopathy: standard and new treatments.
Marín E; Uribe M
Rev Invest Clin; 1990 Jul; 42 Suppl():141-8. PubMed ID: 19256154
[TBL] [Abstract][Full Text] [Related]
15. Potential targeted therapies for the inflammatory pathogenesis of hepatic encephalopathy.
Luo M; Liu H; Hu SJ; Bai FH
Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):665-73. PubMed ID: 26216028
[TBL] [Abstract][Full Text] [Related]
16. Pathogenetic mechanisms of hepatic encephalopathy.
Häussinger D; Schliess F
Gut; 2008 Aug; 57(8):1156-65. PubMed ID: 18628377
[TBL] [Abstract][Full Text] [Related]
17. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.
Moreno-Aspitia A; Perez EA
Clin Ther; 2009 Aug; 31(8):1619-40. PubMed ID: 19808124
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
Manchikanti L; Datta S; Smith HS; Hirsch JA
Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
[TBL] [Abstract][Full Text] [Related]
19. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy.
Mullen KD
Aliment Pharmacol Ther; 2007 Feb; 25 Suppl 1():11-6. PubMed ID: 17295847
[TBL] [Abstract][Full Text] [Related]
20. [In liver cirrhosis, not every "ammonia lowering drug" improves neuropsychiatric deficit].
MMW Fortschr Med; 2001 Mar; 143(9):58. PubMed ID: 11288540
[No Abstract] [Full Text] [Related]
[Next] [New Search]
